Assured Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-20,522
| Closed | -$2.77M | – | 1010 |
|
|
2019
Q1 | $2.77M | Sell |
20,522
-17,424
| -46% | -$2.36M | 0.03% | 226 |
|
|
2018
Q4 | $3.69M | Buy |
37,946
+4,218
| +13% | +$411K | 0.1% | 233 |
|
|
2018
Q3 | $4.69M | Buy |
33,728
+14,766
| +78% | +$2.05M | 0.09% | 240 |
|
|
2018
Q2 | $2.35M | Sell |
18,962
-46,184
| -71% | -$5.73M | 0.04% | 352 |
|
|
2018
Q1 | $7.26M | Buy |
65,146
+7,630
| +13% | +$850K | 0.17% | 139 |
|
|
2017
Q4 | $6.88M | Buy |
57,516
+12,192
| +27% | +$1.46M | 0.14% | 142 |
|
|
2017
Q3 | $6.36M | Buy |
45,324
+24,723
| +120% | +$3.47M | 0.13% | 126 |
|
|
2017
Q2 | $2.51M | Buy |
20,601
+14,121
| +218% | +$1.72M | 0.05% | 181 |
|
|
2017
Q1 | $786K | Buy |
+6,480
| New | +$786K | 0.02% | 313 |
|
|
2016
Q4 | – | Sell |
-4,722
| Closed | -$579K | – | 677 |
|
|
2016
Q3 | $579K | Buy |
+4,722
| New | +$579K | 0.01% | 367 |
|
|
2015
Q2 | – | Sell |
-1,145
| Closed | -$198K | – | 713 |
|
|
2015
Q1 | $198K | Buy |
+1,145
| New | +$198K | ﹤0.01% | 385 |
|